Blockade of interleukin-8 receptor signalling inhibits cyst development in vitro, via suppression of cell proliferation in autosomal polycystic kidney disease

Nephrology

Volumn 19, Issue 8, 2014, Pages 471-478

  Lee, Eun Ji ^a   Song, Seon Ah ^a   Mun, Hyo Won ^a   Yoo, Kyung Hyun ^a   Choi, Soo Young ^b   Park, Eun Young ^a   Park, Jong Hoon ^a  

^a Sookmyung Women's University   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Autosomal polycystic kidney disease; cystogenesis; interleukin 8

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; INTERLEUKIN 8 RECEPTOR; INTERLEUKIN 8 RECEPTOR ANTAGONIST; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; INTERLEUKIN 8;

ARTICLE; CELL COUNT; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CELL CULTURE; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; XTT ASSAY; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; PATHOLOGY; PHYSIOLOGY; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INTERLEUKIN-8; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RECEPTORS, INTERLEUKIN-8; SIGNAL TRANSDUCTION;

EID: 84904888840     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12261     Document Type: Article

References (23)

1. Harris PC, Torres VE,. Polycystic kidney disease. Annu. Rev. Med. 2009; 60: 321-337.
2. Anyatonwu GI, Ehrlich BE,. Calcium signaling and polycystin-2. Biochem. Biophys. Res. Commun. 2004; 322: 1364-1373.
3. Ye M, Grant M, Sharma M, et al. Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro. J. Am. Soc. Nephrol. 1992; 3: 984-994.
4. Gardner KD Jr, Burnside JS, Elzinga LW, Locksley RM,. Cytokines in fluids from polycystic kidneys. Kidney Int. 1991; 39: 718-724.
5. Park EY, Woo YM, Park JH,. Polycystic kidney disease and therapeutic approaches. BMB Rep. 2011; 44: 359-368.
6. Baggiolini M, Clark-Lewis I,. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 1992; 307: 97-101.
7. Li MQ, Luo XZ, Meng YH, et al. CXCL8 enhances proliferation and growth and reduces apoptosis in endometrial stromal cells in an autocrine manner via a CXCR1-triggered PTEN/AKT signal pathway. Hum. Reprod. 2012; 27: 2107-2116.
8. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI,. Characterization of two high affinity human interleukin-8 receptors. J. Biol. Chem. 1992; 267: 16283-16287.
9. Xie K,. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 2001; 12: 375-391.
10. Ginestier C, Liu S, Diebel ME, et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J. Clin. Invest. 2010; 120: 485-497.
11. Yoo KH, Sung YH, Yang MH, et al. Inactivation of Mxi1 induces Il-8 secretion activation in polycystic kidney. Biochem. Biophys. Res. Commun. 2007; 356: 85-90.
12. Schreiber-Agus N, Meng Y, Hoang T, et al. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 1998; 393: 483-487.
13. Gabow PA, Johnson AM, Kaehny WD, et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992; 41: 1311-1319.
14. Helal I, Reed B, Schrier RW,. Emergent early markers of renal progression in autosomal-dominant polycystic kidney disease patients: Implications for prevention and treatment. Am. J. Nephrol. 2012; 36: 162-167.
15. Norman J,. Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). Biochim. Biophys. Acta 2011; 1812: 1327-1336.
16. Vernon MA, Mylonas KJ, Hughes J,. Macrophages and renal fibrosis. Semin. Nephrol. 2010; 30: 302-317.
17. Wu S, Shang H, Cui L, et al. Targeted blockade of interleukin-8 abrogates its promotion of cervical cancer growth and metastasis. Mol. Cell. Biochem. 2013; 375: 69-79.
18. Qin Y, Fan F, Zhao Y, et al. Recombinant human CXCL8(3-72)K11R/G31P regulates smooth muscle cell proliferation and migration through blockage of interleukin-8 receptor. IUBMB Life 2013; 65: 67-75.
19. Ta MH, Harris DC, Rangan GK,. Role of interstitial inflammation in the pathogenesis of polycystic kidney disease. Nephrology (Carlton) 2013; 18: 317-330.
20. Swenson-Fields KI, Vivian CJ, Salah SM, et al. Macrophages promote polycystic kidney disease progression. Kidney Int. 2013; 83: 855-864.
21. Martinez FO, Sica A, Mantovani A, Locati M,. Macrophage activation and polarization. Front. Biosci. 2008; 13: 453-461.
22. Mrug M, Zhou J, Woo Y, et al. Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int. 2008; 73: 63-76.
23. Karihaloo A, Koraishy F, Huen SC, et al. Macrophages promote cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 2011; 22: 1809-1814.